W. Zhang

LBA93 EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)

Ying Cheng, Ying Liu, W. Zhang et al. · Annals of Oncology · 2023 · 26 citations · Full text

Medicine, Oncology, Pharmacology +10

96O Camrelizumab or placebo plus carboplatin and paclitaxel as first-line treatment for advanced squamous NSCLC (CameL-sq): A randomized, double-blind, multicenter, phase III trial

C. Zhou, Shengxiang Ren, J. Chen et al. · Journal of Thoracic Oncology · 2021 · 20 citations · Full text

Medicine, Oncology, Pharmacology +9

LBA56 ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC)

Caicun Zhou, Lin Wu, Yun Fan et al. · Annals of Oncology · 2020 · 17 citations

Medicine, Oncology, Pharmacology +13

OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial

Yuan‐Yuan Cheng, R Yang, J. Chen et al. · Journal of Thoracic Oncology · 2023 · 12 citations · Full text

Medicine, Oncology, Pharmacology +7